Prostatis Group’s Citigroup C Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$649K Buy
4,635
+37
+0.8% +$4.82K 0.15% 100
2026
Q1
$521K Buy
4,598
+67
+1% +$7.63K 0.13% 102
2025
Q4
$529K Buy
+4,531
New +$471K 0.13% 102
2023
Q3
Sell
-24,152
Closed -$25.4K 125
2023
Q2
$25.4K Buy
+24,152
New +$1.13M 0.01% 218
2021
Q2
Sell
-8,886
Closed -$646K 104
2021
Q1
$646K Buy
+8,886
New +$593K 0.51% 51

Other funds holding C

Prostatis Group's C Position: Q2 2026 in Review

Prostatis Group increased its Citigroup (C) stake by 0.8% in Q2 2026, buying an estimated $4.82K and bringing the position to 4,635 shares worth $649K. The position accounts for 0.15% of the portfolio, ranked #100.

Prostatis Group first reported a position in C in Q1 2021 and has held it in 5 quarters since. 2,625 funds tracked by Wall St. Rank hold C as of Q2 2026.

  • Prostatis Group held 4,635 shares of Citigroup worth $649K as of Q2 2026.
  • Prostatis Group bought 37 Citigroup shares in Q2 2026, an estimated $4.82K.
  • Citigroup made up 0.15% of Prostatis Group's portfolio in Q2 2026, its #100 holding.
  • Prostatis Group first reported a position in Citigroup in Q1 2021 and has held it in 5 quarters since.
  • 2,625 funds tracked by Wall St. Rank held Citigroup as of Q2 2026.

Based on Prostatis Group's 13F filing for Q2 2026, filed 14 Aug 2026.